Abstract
The effective reproduction number R is a prominent statistic for inferring the transmissibility of infectious diseases and effectiveness of interventions. R purportedly provides an easy-to-interpret threshold for deducing whether an epidemic will grow (R>1) or decline (R<1). We posit that this interpretation can be misleading and statistically overconfident when applied to infections accumulated from groups featuring heterogeneous dynamics. These groups may be delineated by geography, infectiousness or sociodemographic factors. In these settings, R implicitly weights the dynamics of the groups by their number of circulating infections. We find that this weighting can cause delayed detection of outbreak resurgence and premature signalling of epidemic control because it underrepresents the risks from highly transmissible groups. Applying E-optimal experimental design theory, we develop a weighting algorithm to minimise these issues, yielding the risk averse reproduction number E. Using simulations, analytic approaches and real-world COVID-19 data stratified at the city and district level, we show that E meaningfully summarises transmission dynamics across groups, balancing bias from the averaging underlying R with variance from directly using local group estimates. An E>1 generates timely resurgence signals (upweighting risky groups), while an E<1 ensures local outbreaks are under control. We propose E as an alternative to R for informing policy and assessing transmissibility at large scales (e.g., state-wide or nationally), where R is commonly computed but well-mixed or homogeneity assumptions break down.
Author Summary How can we meaningfully summarise the transmission dynamics of an infectious disease? This question, although fundamental to epidemiology and crucial for informing the design and implementation of interventions (e.g., quarantines), is still not resolved. Current practice is to estimate the effective reproduction number R, which counts the average number of new infections generated per past infection, at large scales (e.g., nationally). An estimated R>1 signals epidemic growth. While R is easily interpreted and computed in real time, it averages infections across diverse locations or socio-demographic groups that likely possess different transmission dynamics. We prove that this averaging in R reduces sensitivity to resurgence, making R>1 slow to reflect realistic epidemic growth. This delay can substantially misinform policymakers and impede interventions. We apply optimal design theory to derive the risk averse reproduction number E as an alternative summary of diverse transmission dynamics. Using mathematical arguments, simulations and empirical COVID-19 datasets, we show that E>1 is an improved threshold for resurgence, providing timelier signals for informing policy or interventions and better uncertainty quantification. Further, E maintains the computability and interpretability of R. We propose E as meaningful statistic at large scales, where the averaging within R likely misrepresents the diversity of transmission dynamics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
KVP acknowledges funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. UO was supported by a grant from Tel Aviv University Center for AI and Data Science 417 (TAD) in collaboration with Google, as part of the initiative of AI and DS for social good. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Additional analyses of 5 empirical datasets and mathematical arguments on the properties of the proposed statistic.
Data Availability
We provide open-source software to reproduce all analyses at https://github.com/kpzoo/risk-averse-R-numbers. While the main code for generating the figures in this text is written in MATLAB, we also include functions in R to compute E on user-defined datasets.
